BioCentury
ARTICLE | Company News

Ablexis unveils AlivaMab Mouse deals

October 27, 2010 12:02 AM UTC

Ablexis LLC (San Francisco, Calif.) granted Pfizer Inc. (NYSE:PFE) and four other pharma companies non-exclusive rights to use its AlivaMab Mouse transgenic mouse technology to discovery human antibod...